​
​

PolyPid (PYPD) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

PYPD Stock Forecast

PolyPid stock forecast is as follows: an average price target of $10.00 (represents a 191.55% upside from PYPD’s last price of $3.43) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

PYPD Price Target

The average price target for PolyPid (PYPD) is $10.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $10.00. This represents a potential 191.55% upside from PYPD's last price of $3.43.

PYPD Analyst Ratings

Buy

According to 4 Wall Street analysts, PolyPid's rating consensus is 'Buy'. The analyst rating breakdown for PYPD stock is 0 'Strong Buy' (0.00%), 3 'Buy' (75.00%), 1 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

PolyPid Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 04, 2024Chase KnickerbockerCraig-Hallum--200.30%191.55%
Row per page
Go to

The latest PolyPid stock forecast, released on Nov 04, 2024 by Chase Knickerbocker from Craig-Hallum, set a price target of $10.00, which represents a 200.30% increase from the stock price at the time of the forecast ($3.33), and a 191.55% increase from PYPD last price ($3.43).

PolyPid Price Target by Period

1M3M12M
# Anlaysts111
Avg Price Target$10.00$10.00$10.00
Last Closing Price$3.43$3.43$3.43
Upside/Downside191.55%191.55%191.55%

In the current month, the average price target of PolyPid stock is $10.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 191.55% increase as opposed to PolyPid's last price of $3.43. This month's average price target is down 0.00% compared to last quarter, and down 0.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Nov 04, 2024Craig-HallumBuyInitialise
Sep 06, 2022Raymond JamesOutperformDowngrade
Sep 02, 2022GuggenheimNeutralUpgrade
Aug 11, 2022BMO CapitalOutperformOutperformHold
Row per page
Go to

PolyPid's last stock rating was published by Craig-Hallum on Nov 04, 2024. The company Initialise its PYPD rating from "null" to "Buy".

PolyPid Financial Forecast

PolyPid Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
Revenue-----------
Avg Forecast$2.30M$1.20M$300.00K--------
High Forecast$2.30M$1.20M$300.00K--------
Low Forecast$2.30M$1.20M$300.00K--------
# Analysts111--------
Surprise %-----------

PolyPid's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. PYPD's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

PolyPid EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts111--------
EBITDA-----------
Avg Forecast-----------
High Forecast-----------
Low Forecast-----------
Surprise %-----------

undefined analysts predict PYPD's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than PolyPid's previous annual EBITDA (undefined) of $NaN.

PolyPid Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts111--------
Net Income-----------
Avg Forecast$-2.11M$-2.46M$-2.41M$-2.16M$-2.62M$-2.91M$-3.38M$-4.50M$-5.42M$-5.04M$-6.53M
High Forecast$-2.11M$-2.46M$-2.41M$-2.16M$-2.62M$-2.91M$-3.38M$-4.50M$-5.42M$-5.04M$-6.53M
Low Forecast$-2.11M$-2.46M$-2.41M$-2.16M$-2.62M$-2.91M$-3.38M$-4.50M$-5.42M$-5.04M$-6.53M
Surprise %-----------

PolyPid's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. PYPD's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

PolyPid SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts111--------
SG&A-----------
Avg Forecast-----------
High Forecast-----------
Low Forecast-----------
Surprise %-----------

PolyPid's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to PYPD last annual SG&A of $NaN (undefined).

PolyPid EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts111--------
EPS-----------
Avg Forecast$-0.42$-0.49$-0.48$-0.43$-0.52$-0.58$-0.67$-0.90$-1.08$-1.00$-1.30
High Forecast$-0.42$-0.49$-0.48$-0.43$-0.52$-0.58$-0.67$-0.90$-1.08$-1.00$-1.30
Low Forecast$-0.42$-0.49$-0.48$-0.43$-0.52$-0.58$-0.67$-0.90$-1.08$-1.00$-1.30
Surprise %-----------

According to undefined Wall Street analysts, PolyPid's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to PYPD previous annual EPS of $NaN (undefined).

PolyPid Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
INABIN8bio--4275.00%Buy
KPRXKiora Pharmaceuticals--3525.38%Buy
BWVOnconetix--2122.22%Buy
ELEVElevation Oncology--1375.41%Buy
VRPXVirpax Pharmaceuticals--408.47%
INMBINmune Bio--362.18%Buy
VACCBarinthus Biotherapeutics--340.00%
PYXSPyxis Oncology--328.57%Buy
CUECue Biopharma--320.39%Buy
ANEBAnebulo Pharmaceuticals--300.00%Buy
ZURAZura Bio--241.30%Buy
PYPDPolyPid--191.55%Buy
ANIXAnixa Biosciences--145.10%Buy
EFTReFFECTOR Therapeutics---Buy

PYPD Forecast FAQ

Is PolyPid a good buy?

Yes, according to 4 Wall Street analysts, PolyPid (PYPD) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 75.00% of PYPD's total ratings.

What is PYPD's price target?

PolyPid (PYPD) average price target is $10 with a range of $10 to $10, implying a 191.55% from its last price of $3.43. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will PolyPid stock go up soon?

According to Wall Street analysts' prediction for PYPD stock, the company can go up by 191.55% (from the last price of $3.43 to the average price target of $10), up by 191.55% based on the highest stock price target, and up by 191.55% based on the lowest stock price target.

Can PolyPid stock reach $5?

PYPD's average twelve months analyst stock price target of $10 supports the claim that PolyPid can reach $5 in the near future.

What is PolyPid's current price target trend?

1 Wall Street analyst forecast a $10 price target for PolyPid (PYPD) this month, up 191.55% from its last price of $3.43. Compared to the last 3 and 12 months, the average price target increased by 191.55% and increased by 191.55%, respectively.

What are PolyPid's analysts' financial forecasts?

PolyPid's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-13.42M (high $-13.42M, low $-13.42M), average SG&A $0 (high $0, low $0), and average EPS is $-2.671 (high $-2.671, low $-2.671). PYPD's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $3.8M (high $3.8M, low $3.8M), average EBITDA is $0 (high $0, low $0), average net income is $-9.145M (high $-9.145M, low $-9.145M), average SG&A $0 (high $0, low $0), and average EPS is $-1.82 (high $-1.82, low $-1.82).